1-20 of 341 results for subject:Screening
Librarians' tools
- Search time
- 0.317 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:Screening
- We searched for
- subject_t:Screening OR subject_ses:92923
Type
House
Session
Month
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
I am sure that my hon. Friend is right about the distress it must cause. If he can provide me with further details, I will ask Health Ministers to advise on the circumstances he has brought to the House’s attention.
I am sure that my hon. Friend is right about the distress it must cause. If he can provide me with further details, I will ask Health Ministers to advise on the circumstances he has brought to the House’s attention.
May we have a debate on what constitutes “high risk” when it comes to referrals for breast cancer screening? A constituent of mine whose mother and two sisters have sadly been diagnosed with breast cancer has bizarrely not been assessed as high risk and, as a consequence, has been denied...
May we have a debate on what constitutes “high risk” when it comes to referrals for breast cancer screening? A constituent of mine whose mother and two sisters have sadly been diagnosed with breast cancer has bizarrely not been assessed as high risk and, as a consequence, has been denied...
I am very grateful to have the opportunity to raise this subject in Parliament. It was first brought to my attention by a constituent; I will obviously keep her name confidential, but she is content for me to discuss her experiences, which are not unusual. Hypothyroidism is not a small...
I am very grateful to have the opportunity to raise this subject in Parliament. It was first brought to my attention by a constituent; I will obviously keep her name confidential, but she is content for me to discuss her experiences, which are not unusual. Hypothyroidism is not a small...
In her introduction, the hon. Lady mentioned that about one in 50 women and about one in 1,000 men develop the disease in their lifetime. Does she agree that if someone has a family history of the disease, perhaps at a certain stage of life there should be a check...
In her introduction, the hon. Lady mentioned that about one in 50 women and about one in 1,000 men develop the disease in their lifetime. Does she agree that if someone has a family history of the disease, perhaps at a certain stage of life there should be a check...
I thank the hon. Gentleman for his intervention, because that is an excellent suggestion; it is what I would describe as a no-brainer. If someone has a family history of the disease, surely that should be a very strong indication for the GP to be proactive in monitoring the possibility...
I thank the hon. Gentleman for his intervention, because that is an excellent suggestion; it is what I would describe as a no-brainer. If someone has a family history of the disease, surely that should be a very strong indication for the GP to be proactive in monitoring the possibility...
It is a pleasure to serve under your chairmanship, Sir Roger. I congratulate my right hon. Friend the Member for Meriden (Mrs Spelman) on securing a debate on this issue. This is, as she says, an opportunity to highlight something that we do not discuss often in Parliament. I hope...
It is a pleasure to serve under your chairmanship, Sir Roger. I congratulate my right hon. Friend the Member for Meriden (Mrs Spelman) on securing a debate on this issue. This is, as she says, an opportunity to highlight something that we do not discuss often in Parliament. I hope...
My hon. Friend the Minister is coming towards the end of her remarks. Perhaps when she writes to the Royal College of General Practitioners, she will mention the excellent point raised by the hon. Member for Strangford (Jim Shannon). Where there is a family history of hypothyroidism, we should be...
My hon. Friend the Minister is coming towards the end of her remarks. Perhaps when she writes to the Royal College of General Practitioners, she will mention the excellent point raised by the hon. Member for Strangford (Jim Shannon). Where there is a family history of hypothyroidism, we should be...
That is a good point. There is some information on the NHS website, but I will certainly include that point in my letter, and hopefully I will get a response from the royal college, which I will pass on. The hon. Member for Strangford (Jim Shannon) takes a fantastic interest...
That is a good point. There is some information on the NHS website, but I will certainly include that point in my letter, and hopefully I will get a response from the royal college, which I will pass on. The hon. Member for Strangford (Jim Shannon) takes a fantastic interest...
To ask the Secretary of State for Health if he will take steps to ensure that every man has a health MOT with his GP between the ages of 40 and 50.
To ask the Secretary of State for Health if he will take steps to ensure that every man has a health MOT with his GP between the ages of 40 and 50.
Men aged between 40 and 74 who have not been diagnosed with an existing vascular disease or are being treated for certain risk factors should be offered an NHS Health Check every five years. The NHS Health Check is a risk assessment and risk management programme, commissioned by local authorities, aimed at preventing heart disease, stroke,
diabetes, and kidney disease. Every individual attending an NHS Health Check receives a personal assessment, setting out their level of risk and exactly what they can do to reduce it and where necessary, is referred to their general practitioner for further tests or treatment.
In November 2012, the Department launched the healthy living and social care theme of the red tape challenge. The Department sought comments on regulations affecting business and civil society through the red tape challenge website and responses from a range of different groups were received on a number of areas.
The...
In November 2012, the Department launched the healthy living and social care theme of the red tape challenge. The Department sought comments on regulations affecting business and civil society through the red tape challenge website and responses from a range of different groups were received on a number of areas.
The...
My honourable friend the Parliamentary Under-Secretary of State, Department of Health (Jane Ellison) has made the following Written Ministerial Statement.
In November 2012, the department launched the healthy living and social care theme of the Red Tape Challenge. The department sought comments on regulations affecting business and civil society through the...
My honourable friend the Parliamentary Under-Secretary of State, Department of Health (Jane Ellison) has made the following Written Ministerial Statement.
In November 2012, the department launched the healthy living and social care theme of the Red Tape Challenge. The department sought comments on regulations affecting business and civil society through the...
To ask the Secretary of State for Health what steps his Department is taking to improve the prevention and earlier diagnosis of (a) kidney, (b) stomach, (c) ovarian and (d) colorectal cancer.
To ask the Secretary of State for Health what steps his Department is taking to improve the prevention and earlier diagnosis of (a) kidney, (b) stomach, (c) ovarian and (d) colorectal cancer.
Along with our partners in Public Health England, we are taking wide-ranging action to tackle risk factors for the prevention of diseases, including cancer, and addressing: tobacco use; obesity; unhealthy diets; physical inactivity; and harmful consumption of alcohol. Key elements of the work programme involve action at the national level, including working with industry through the Public Health Responsibility Deal, alongside strengthening local action, promoting healthy choices, and giving appropriate information to support healthier lives through social marketing campaigns such as Change4Life.
On the prevention of cancer specifically, we are offering vaccination of young women against human papillomavirus, which is known to cause most cervical cancers, and funding activity on skin cancer prevention.
In partnership with the Department and NHS England (including NHS Improving Quality), Public Health England has taken on the running of the Be Clear on Cancer (BCOC) campaigns to highlight the symptoms of a range of cancers and to encourage people with the relevant symptoms to visit their general practitioner. To date we have run national BCOC campaigns to raise awareness on "blood in poo" as a symptom of bowel cancer and "blood in pee" as a symptom of kidney (and bladder) cancer. We have run local pilots for ovarian and oesophagogastric cancers. The oesophagogastric cancer pilot covered symptoms of oesophageal and stomach cancers. These campaigns have now been upgraded and in early 2014 will run as regional pilots. We have also run national campaigns on lung cancer.
Cancer screening is also an important way to detect cancer early. Since it began inviting men and women aged 60 to 69 in 2006 (now extended to men and women aged up to 75), over 12 million home testing kits have been returned completed as part of the NHS Bowel Cancer Screening Programme, and over 17,500 cancers diagnosed. Public Health England is now piloting Bowel Scope Screening (BSS), a one-off complementary screening method to the home testing kits for men and women aged 55, with the potential to save 3,000 lives a year. The Secretary of State's commitment is to have the BSS programme rolled out to 60% of England by the end of March 2015, and the rest of England by the end of 2016.
Improving outcomes: a strategy for cancer third annual report. 80 p.
Improving outcomes: a strategy for cancer third annual report. 80 p.
To ask the Secretary of State for Health what the average cost of a mammogram is in England and Wales.
To ask the Secretary of State for Health what the average cost of a mammogram is in England and Wales.
The information is not available.
The Department collects reference costs annually from national health service, trusts and NHS foundation trusts in England. Reference costs are the average unit cost to the NHS of providing defined services in a given financial year to NHS patients.
Reference costs for acute health care services are collected by Healthcare Resource Group (HRG), which are standard groupings of clinically similar treatments which use similar levels of health care resource. However, mammography is not taken into account for the purpose of grouping to HRGs, and its costs are included in the cost of the patient attendance or episode where the diagnostic occurred.
Health is a devolved matter in Wales.
To ask the Secretary of State for Health how many and what percentage of prisoners in England received a hepatitis B test in (a) 2008, (b) 2009, (c) 2010, (d) 2011, (e) 2012 and (f) 2013 to date.
To ask the Secretary of State for Health how many and what percentage of prisoners in England received a hepatitis B test in (a) 2008, (b) 2009, (c) 2010, (d) 2011, (e) 2012 and (f) 2013 to date.
We do not have data on the total number of prisoners in England tested for hepatitis B virus infection. The reasons for this are that not all tests performed on serving prisoners are identified and the information is not collected centrally.
Public Health England does have a sentinel surveillance system which is used to monitor trends in blood-borne virus testing in 24 participating laboratories receiving samples from prisons across England. The reports from these laboratories do not represent the totality of testing conducted on prisoners throughout the prison estate but rather are used to identify changes in the level of testing for Hepatitis B (and Hepatitis C) virus infection among prisons covered by the participating laboratories. These data show that:
2008: 2,415 prisoners were tested (estimated 1.5% coverage)
2009: 2,992 prisoners were tested (estimated 1.8% coverage)
2010: 2,860 prisoners were tested (estimated 1.7% coverage)
2011: 3,463 prisoners were tested (estimated 2.0% coverage)
2012: 3,441 prisoners were tested (estimated 2.0% coverage).
We do not yet have data for 2013.
To ask the Secretary of State for Health what steps his Department has taken to increase the number of people screened for (a) hepatitis B and (b) hepatitis C; and if he will make a statement.
To ask the Secretary of State for Health what steps his Department has taken to increase the number of people screened for (a) hepatitis B and (b) hepatitis C; and if he will make a statement.
Public Health England (PHE) has contributed to National Institute for Health and Care Excellence (NICE) guidance on hepatitis B and C1, and guidance on hepatitis B antenatal screening and newborn immunisation programme2, both of which make recommendations to increase uptake of testing.
PHE leads or collaborates on research projects to pilot models and develop best practice in contact tracing and management of dose contacts of hepatitis B individuals (mainly pregnant women identified through antenatal screening), and improved screening of patients for hepatitis B and C in primary care.
PHE has developed novel testing methods to improve point of care testing for hepatitis B and C in community settings, such as dried blood spot and oral fluid testing.
PHE offers a national dried blood spot testing service for infants born to mothers infected with hepatitis B as part of an initiative to improve testing for chronic hepatitis at 12 months of age.
PHE works collaboratively with NHS and non-governmental organisations to advocate for increased uptake of screening for hepatitis B and C.1 Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection; Issued: December 2012 last modified: March 2013
NICE public health guidance 43.
http://publications.nice.org.uk/hepatitis-b-and-c-ways-to-promote-and-offer-testing-to-people-at-increased-risk-of-infection-ph43/considerations2 Department of Health. Hepatitis B antenatal screening and newborn immunisation programme:
Best practice guidance 2011
www.gov.uk/government/uploads/system/uploads/attachment_data/file/215622/dh_132637.pdf
I. Standards for local surveillance and follow up of Hepatitis B and C. 63 p. II. Hepatitis: frequently asked questions. Briefing for councillors. 8 p.
I. Standards for local surveillance and follow up of Hepatitis B and C. 63 p. II. Hepatitis: frequently asked questions. Briefing for councillors. 8 p.
To ask Her Majesty’s Government what scanning programmes the National Health Service has available to detect the possibility of placenta disintegration in pregnant women.[HL3682]
To ask Her Majesty’s Government what scanning programmes the National Health Service has available to detect the possibility of placenta disintegration in pregnant women.[HL3682]
Placenta disintegration is not a recognised medical term. Therefore the Department has not made an assessment of the scale of occurrence.